期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Pathogenesis and treatment of hepatitis C virus-related liver diseases

Pathogenesis and treatment of hepatitis C virus-related liver diseases
下载PDF
导出
摘要 BACKGROUND: Few comprehensive reviews on the pa- thogenesis of hepatitis C virus (HCV)-related liver diseases have been presented to the present. This article was to re- view the pathogenesis and treatment of HCV-related liver diseases. DATA SOURCES: Data presented here are mostly taken from Japanese studies. RESULTS: HCV infection is characterized by persistent in- flammation of the liver and frequent development of hepa- tocellular carcinoma (HCC) in most cases. These charac- teristic evidences could be explained by immunological al- terations and oxidative stress in the hepatocyte caused by HCV infection. Interferon (IFN) treatment is carried out, at present, not only for the elimination of infected HCV for the treatment of chronic liver diseases, but also for both the prevention of HCC and the treatment of advanced HCC with chemotherapy. The treatment for oxidative stress is al- so important for non-responders to IFN. CONCLUSION: It is important to understand the pathoge- nesis of HCV-related liver diseases for a successful treat- ment. BACKGROUND: Few comprehensive reviews on the pa- thogenesis of hepatitis C virus (HCV)-related liver diseases have been presented to the present. This article was to re- view the pathogenesis and treatment of HCV-related liver diseases. DATA SOURCES: Data presented here are mostly taken from Japanese studies. RESULTS: HCV infection is characterized by persistent in- flammation of the liver and frequent development of hepa- tocellular carcinoma (HCC) in most cases. These charac- teristic evidences could be explained by immunological al- terations and oxidative stress in the hepatocyte caused by HCV infection. Interferon (IFN) treatment is carried out, at present, not only for the elimination of infected HCV for the treatment of chronic liver diseases, but also for both the prevention of HCC and the treatment of advanced HCC with chemotherapy. The treatment for oxidative stress is al- so important for non-responders to IFN. CONCLUSION: It is important to understand the pathoge- nesis of HCV-related liver diseases for a successful treat- ment.
作者 Kyuichi Tanikawa
机构地区 Kurume
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2004年第1期17-20,共4页 国际肝胆胰疾病杂志（英文版）
关键词 hepatitis C virus hepatitis C virus-related liver diseases interferon therapy hepatitis C virus hepatitis C virus-related liver diseases interferon therapy
分类号 R512.63 [医药卫生—内科学]
  • 相关文献

参考文献26

  • 1Jinushi M,,Takehara T,Kanto T,Tatsumi T,Groh V,Spies T, et al.Critical role of MHC class I-related chain A and B ex- pression on IFN-α-stimulated dendritic cells in NK cell activa- tion: impairment in chronic hepatitis C virus infection. J Im- munol . 2003
  • 2Okuda M,Li K,Beard MR,Showalter LA,Scholle F,Le- mon SM, et al.Mitochondrial injury, oxidative stress, and an- tioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology . 2002
  • 3Barbara G,Lorenzo GD,Asti A,Ribersani M,Belloni G,Grisorio B, et al.Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemi- cal findings. The American journal of Gastroenterology . 1999
  • 4Kato N,Yoshida H,Kioko Ono-Nita S,Kato J,Goto T,Otsuka M, et al.Activation of intracellular signaling by hepati- tis B and C viruses; C-viral core is the most potent signal in- ducer. Hepatology . 2000
  • 5Herbay A,Stahl W,Niederau C,Sies H.Vitamin E improves the aminotransferase status of patients suffering from viral hepati- tis C: a randomized, double-blind, placebo-controlled study. Free Radical Research . 1997
  • 6Oritz V,,Berenguer M, JM,,Carrasco D,Berenguer J.Contribution of obesity to hepatitis C-related fibrosis progres- sion. The American journal of Gastroenterology . 2002
  • 7Cortez-Pinto H.Oxidative stress in alcoholic and non-alcoho- lic liver disease. Falk Symposium 121. Steatohepatkis (NASH and ASH) . 2001
  • 8Kawaguchi T,Harada M,Yoshida T,Taniguchi E,Kumemu- ra H,Hanada S, et al.Insulin resistance through down regula- tion of insulin receptor substrate (IRS)-1 and IRS-2 in pa- tients with chronic hepatitis C virus infection. Hepatology . 2003
  • 9Miyakawa H,Sato C,Izumi N,Tazawa J,Ebata A,Hattori K, et al.Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: its contribution to the development of hepatocellular carcinoma. Alcohol and Alcoholism . 1993
  • 10Yoshida H,Shiratori Y,Moriyama M,Arakawa Y,Ide T,Sa- ta M, et al.Interferon therapy reduces the risk for hepatocellu- lar carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann In- tern Med . 1999

共引文献2

Hepatobiliary & Pancreatic Diseases International
2004年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部